Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
Published on: October 6, 2023
Impact upfront: novel format for Novo Nordisk Foundation funding
Gert Vilhelm Balling1, Henrik Barslund Fosse2, Katrine Zander Iversen2
1Impact Management, Novo Nordisk Foundation, Hellerup, Denmark. gvb@novo.dk.
Abstract:
Many retrospective assessments of the wider, societal impacts from health research funding use the Payback Framework or other frameworks. Much of this experience was collated in the 2018 Statement by the International School on Research Impact Assessment (ISRIA). Despite increased interest, especially in engaged research and a wider range of evaluation approaches, rarely do health and other research funders take a prospective approach and analyse the potential impact from a proposal to inform an impact management approach aimed at boosting impact. In this paper, experts from the Novo Nordisk Foundation, a leading philanthropic funder of research, describe how they are developing and applying such a pioneering approach. The five steps form a continuum from project inception to data collation and assessment. The first step entails preparing the project's narrative in alignment with the project's vision. The second, building the logic model, includes defining success factors and effect chains. The third is an early assessment of the initiative's potential impact, conducted on a case basis. The fourth is implementing the data model by integrating specific indicators. The fifth focuses on monitoring, impact management and creating impact products, including developing a comprehensive plan for data reporting and assessment, with scope for adjustments based on experience. This approach aligns with ISRIA guidelines, but further steps are needed. Whilst the Foundation is driving innovation in impact assessment by successfully introducing a new approach that uses prospective impact analysis to inform impact management to enhance the levels of impact achieved, further progress is needed on stakeholder engagement expanding towards a more inclusive stakeholder involvement.
Related Concept Videos
Preclinical Development: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Discovery: Overview

